SNU-5 In Vitro Tumor Cell Target Expression Assay

This assay is to provide SNU-5-based In Vitro Tumor Cell Target Expression Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

SNU-5

Human

SNU-5 was line derived in 1987 by J. Park and associates from ascites of a patient with poorly differentiated carcinoma of the stomach. The patient had previously received chemotherapy including 5-fluorouracil, doxorubicin and mitomycin-C.
Derived from metastatic site, ascites

Gastric Carcinoma

Oncology

In Vitro Tumor Cell Target Expression Assay

SNU-5-cell based In Vitro Tumor Cell Target Expression Assay

Tumor Marker Expression Assay; Inhibitory Ligand Expression Assay

Tumor Cell Analysis Assay

Use FACS technology to analyze the tumor expression markers.